WASHINGTON — President Donald Trump has announced the launch of TrumpRx.gov, a new federal platform designed to provide Americans with access to lower prices on dozens of high-cost, brand-name prescription medications.
According to the administration, the platform uses “Most-Favored-Nation” pricing agreements negotiated with pharmaceutical manufacturers. Those agreements are intended to align U.S. drug prices with the lowest prices paid by other developed nations.
Administration officials say the website is aimed particularly at Americans who face high out-of-pocket costs for medications that are not fully covered by insurance.
Significant Price Reductions Highlighted
The administration pointed to several examples of reduced prices, including medications used for diabetes, weight management, and fertility treatments.
GLP-1 medications — among the highest-spending drug categories in the United States — are listed at substantially lower prices on the platform.
- Monthly prices for Ozempic® are listed at an average of $350, down from more than $1,000, depending on dosage.
- Injectable Wegovy® is listed at an average of $350, with some doses as low as $199.
- The pill form of Wegovy® is listed as low as $149 per month.
- Zepbound® is listed at an average of $346, with some doses as low as $299.
The administration also highlighted potential savings for Americans undergoing fertility treatment, noting that patients often pay out-of-pocket for these medications.
- Gonal-F® is listed at prices as low as $168 per pen, depending on dosage.
- Cetrotide® is listed at $22.50, compared to a previous price of $316.
- Ovidrel® is listed at $84, down from $251.
Officials estimate some patients could save more than $2,000 per fertility treatment cycle under the new pricing structure.
Expansion Planned
The White House said additional pharmaceutical companies are expected to join the platform through similar pricing agreements, with more high-cost medications added over time.
President Trump is also urging Congress to pass what he calls the “Great Healthcare Plan,” which would codify the pricing model into law, expand price transparency requirements, lower insurance premiums, and allow purchases made through TrumpRx.gov to be covered under health insurance plans.
Administration officials describe the launch as an initial step in broader efforts to reduce prescription drug costs nationwide.
